Table 1.
Clinical characteristics of CRC patients from groups of 3 independent public and 1 unpublished databases
| Clinical characteristics | GSE14333 (N = 290) | GSE17537 (N = 55) | GSE17536 (N = 177) | ZJU_CRC (N = 52) |
|---|---|---|---|---|
| Age (yr) | ||||
| Median | 67 | - | - | 61 |
| Range | 26-92 | - | - | 26-93 |
| Average, SD | - | 62.3 ± 14.1 | 65.5 ± 13.1 | 60.2 ± 13.5 |
| Follow-up Time | ||||
| Median | 37.2 | 50.2 | 48.1 | 49.5 |
| Range | 0.9-118.6 | 0.4-111.3 | 0.92-142.6 | 4-100 |
| Terminal Event = Death | ||||
| n (%) | 48 (16.5) | 20 (36.3) | 73 (41.2) | 22 (42.3) |
| Deficiency | 60 (20.7) | - | - | 1 (1.9) |
| Sex (%) | ||||
| Male | - | 30 (54.5) | 96 (54.2) | 29 (55.8) |
| Female | - | 25 (45.5) | 81 (45.8) | 23 (44.2) |
| TNM Stage (%) | ||||
| I | 44 (15.2) | 4 (7.3) | 24 (13.6) | 0 (0) |
| II | 94 (32.4) | 15 (27.3) | 57 (32.2) | 17 (32.7) |
| III | 91 (31.4) | 19 (34.5) | 57 (32.2) | 35 (67.3) |
| IV | 61 (21) | 17 (30.9) | 39 (22) | 0 (0) |
| Lymph Node Metastasis (%) | ||||
| No | 138 (47.6) | 19 (34.5) | 81 (45.8) | 17 (32.7) |
| Yes | 91 (31.4) | 19 (34.5) | 57 (32.2) | 35 (67.3) |
| N/A | 61 (21) | 17 (30.9) | 39 (22) | 0 (0) |